Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Bupivacaine for Pec Block in Breast Surgery
NCT03599635Phase 4Completed
- Sponsor
- University of Minnesota
- Start
- Jul 2018
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of liposomal bupivacaine in acute pain, sponsored by University of Minnesota. Primary endpoint: Total opioid use at 72 hours. Started Jul 2018; status: completed.
02
Drugs
liposomal bupivacaine
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT03599635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03599635.